Dr. Hui's academic interests focus on clinical and biological aspects of gynecological cancers. Using molecular and genetic approaches, he has active research collaborations with clinical oncologists and basic science investigators in exploring the pathogenesis of common gynecological tumors including gestational trophoblastic disease, endometrial carcinomas, cervical cancers and ovarian tumors. As director of the Molecular Diagnostics Laboratory, he has been exploring molecular methods in facilitating histological evaluations of various neoplastic conditions and molecular biomarkers for therapeutic guidance and prognostication.
Specialized Terms: Gynecological tumors including endometrial, cervical and ovarian cancers; Gestational trophoblastic disease; Molecular diagnosis of cancers and molecular genotyping diagnosis of trophoblastic disease.
Adnexal Diseases; Uterine Cervical Neoplasms; Gynecology; Ovarian Neoplasms; Pathology; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms; Endometrial Neoplasms; Molecular Diagnostic Techniques; Gestational Trophoblastic Disease; Genotyping Techniques
Conditions | Study Title |
---|---|
Corpus Uteri; Other Female Genital | A Phase II Evaluation of Afatinib |